ICARE Social Media Post August 2022

Pancreatic Cancer Treatment


A new study reports that maintenance treatment with Olaparib may benefit BRCA1/2 carriers with pancreatic cancer. These findings demonstrated:⁠
long-term survival was more common
time to subsequent therapy was prolonged
Read the full article at the link: https://ascopubs.org/doi/pdf/10.1200/JCO.21.01604⁠
Reference: Kindler et al. J Clin Oncol. 2022; JCO2101604. PMID: 35834777.

Permanent link to this article: https://inheritedcancer.net/post80522/